Gemini Therapeutics (GMTX) Stock Chart & Stock Price History → Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad) Free GMTX Stock Alerts $39.12 +2.66 (+7.30%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends Gemini Therapeutics Stock Price Performance5 Day Performance+15.23%1 Month Performance+33.33%3 Month Performance-40.08%6 Month Performance-32.05%Year-To-Date Performance-32.27%1 Year Performance+0.46% Receive GMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingA New Generation of Billionaires Is About to Be CreatedOn June 30, AI will hit a tipping-point… $15.7 trillion of wealth is at stake. As many as 800 million jobs are caught in AI’s crosshairs…Click here for details. GMTX Stock Chart for Saturday, June, 8, 2024 GMTX Chart by TradingView Gemini Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$37.95$36.46-3.93%$37.88$36.38221,115 shs$1.58 billion06/06/2024$36.57$37.95+3.77%$38.17$36.38550,733 shs$1.64 billion06/05/2024$36.57$36.57$36.99$35.57180,879 shs$1.58 billion06/04/2024$33.95$36.57+7.72%$36.99$35.57180,879 shs$1.58 billion06/03/2024$33.95$33.95$34.87$33.29359,305 shs$1.47 billion05/31/2024$34.63$33.95-1.96%$34.87$33.29353,862 shs$1.47 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$34.66$34.63-0.09%$35.42$33.78257,200 shs$1.50 billion05/29/2024$34.28$34.66+1.11%$36.38$33.56604,950 shs$1.50 billion05/28/2024$34.28$34.28$34.92$31.60565,684 shs$1.49 billion05/27/2024$34.28$34.28$34.92$31.60565,684 shs$1.49 billion05/24/2024$33.17$33.35+0.54%$33.67$32.46408,187 shs$1.44 billion05/23/2024$31.26$33.17+6.11%$33.51$31.03309,533 shs$1.44 billion05/22/2024$32.37$31.26-3.43%$32.23$30.65401,749 shs$1.35 billion05/21/2024$32.18$32.37+0.59%$32.41$30.96200,645 shs$1.40 billion05/20/2024$32.18$32.18$32.48$31.44376,433 shs$1.39 billion05/17/2024$31.86$31.92+0.19%$32.25$31.10228,793 shs$1.38 billion05/16/2024$31.84$31.86+0.06%$33.17$31.56389,231 shs$1.38 billion05/15/2024$31.01$31.84+2.68%$32.31$30.97393,596 shs$1.38 billion05/14/2024$31.01$31.01$32.34$30.79241,334 shs$1.34 billion05/13/2024$30.36$31.01+2.14%$32.34$30.79241,266 shs$1.34 billion05/10/2024$30.77$30.77$31.36$28.25344,682 shs$1.33 billion05/09/2024$29.34$30.77+4.87%$31.36$28.25344,663 shs$1.33 billion05/08/2024$30.04$29.34-2.33%$29.88$28.42275,468 shs$1.27 billion05/07/2024$13.50$30.04+122.52%$30.43$29.42311,351 shs$1.30 billion05/06/2024$29.79$13.50-54.68%$14.10$13.506,380 shs$584.93 million05/03/2024$29.00$29.00$29.77$28.40276,190 shs$1.26 billion05/02/2024$28.53$29.00+1.65%$29.77$28.40276,189 shs$1.26 billion05/01/2024$28.29$28.53+0.85%$29.71$27.79437,334 shs$1.24 billion04/30/2024$28.29$28.29$28.67$27.39227,276 shs$1.23 billion04/29/2024$27.55$28.29+2.69%$28.67$27.39227,271 shs$1.23 billion04/26/2024$26.52$27.55+3.88%$27.90$25.64368,874 shs$1.19 billion04/25/2024$27.00$26.52-1.78%$27.04$25.86314,532 shs$1.15 billion04/24/2024$27.00$27.00$28.53$26.98554,062 shs$1.17 billion04/23/2024$28.69$27.00-5.89%$28.53$26.98554,061 shs$1.17 billion04/22/2024$28.69$28.69$30.06$28.08565,171 shs$1.24 billion04/19/2024$30.02$30.02$30.38$29.85315,938 shs$1.30 billion04/18/2024$30.28$30.02-0.86%$30.38$29.85315,937 shs$1.30 billion04/17/2024$30.52$30.28-0.79%$30.47$29.31334,232 shs$1.31 billion04/16/2024$31.83$30.52-4.12%$32.55$30.39387,341 shs$1.32 billion04/15/2024$31.83$31.83$32.49$31.54408,305 shs$1.38 billionThe new masters of energy (Ad)According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details.04/12/2024$31.52$32.04+1.65%$32.46$30.96426,082 shs$1.39 billion04/11/2024$32.08$31.52-1.75%$31.97$30.40479,392 shs$1.37 billion04/10/2024$31.78$32.08+0.94%$32.89$31.14466,665 shs$1.39 billion04/09/2024$30.10$31.78+5.58%$31.92$29.90504,478 shs$1.38 billion04/08/2024$30.10$30.10$31.15$28.75583,687 shs$1.30 billion04/05/2024$29.50$30.10+2.03%$31.15$28.75583,687 shs$1.30 billion04/04/2024$32.04$29.50-7.91%$31.86$29.34896,485 shs$1.28 billion04/03/2024$34.21$32.04-6.36%$33.00$29.361.48 million shs$1.39 billion04/02/2024$34.21$34.21$35.40$25.606.15 million shs$1.48 billion04/01/2024$62.26$34.21-45.05%$35.40$25.606.15 million shs$1.48 billion03/29/2024$62.26$62.26$62.69$59.20263,991 shs$2.70 billion03/28/2024$60.30$62.26+3.25%$62.69$59.20263,991 shs$2.70 billion03/27/2024$60.30$60.30$60.61$59.00248,993 shs$2.61 billion03/26/2024$59.50$60.30+1.34%$60.61$59.00248,992 shs$2.61 billion03/25/2024$60.61$59.50-1.83%$60.96$58.91251,720 shs$2.58 billion03/22/2024$66.40$61.41-7.52%$68.86$59.54601,133 shs$2.66 billion03/21/2024$67.64$66.40-1.83%$67.80$63.82261,566 shs$2.88 billion03/20/2024$66.04$67.64+2.42%$67.76$65.18194,684 shs$2.93 billion03/19/2024$66.04$66.04$66.43$60.74356,907 shs$2.86 billion03/18/2024$61.78$66.04+6.90%$66.43$60.74348,296 shs$2.86 billion03/15/2024$65.46$63.03-3.71%$65.59$61.65206,347 shs$2.73 billion03/14/2024$65.46$65.46$66.32$63.48233,715 shs$2.84 billion03/13/2024$64.42$65.46+1.61%$66.32$63.48233,715 shs$2.84 billion03/12/2024$65.29$64.42-1.33%$65.69$60.98485,277 shs$2.79 billion03/11/2024$65.29$65.29$66.78$62.76281,430 shs$2.83 billion03/08/2024$66.08$65.29-1.20%$66.78$62.76281,387 shs$2.83 billion03/07/2024$69.04$66.08-4.29%$70.54$64.97309,736 shs$2.86 billion Related Companies: Blueprint Medicines Stock Price Chart Viking Therapeutics Stock Price Chart Ionis Pharmaceuticals Stock Price Chart Cytokinetics Stock Price Chart Summit Therapeutics Stock Price Chart Organon & Co. Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Nuvalent Stock Price Chart BridgeBio Pharma Stock Price Chart Apellis Pharmaceuticals Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gemini Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.